Some of the effects of the selective sigma ligand (+)pentazocine are mediated via a naloxone-sensitive receptor

Synapse

Volumn 39, Issue 4, 2001, Pages 323-331

  Couture, Sophie ^a   Debonnel, Guy ^b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Cyclazocine; Electrophysiology; Hippocampus; NMDA; Opiate; Sigma

Indexed keywords

CYPRODIME; IGMESINE; LIGAND; N [2 (3,4 DICHLOROPHENYL)ETHYL] N METHYL 2 (1 PYRROLIDINYL)CYCLOHEXYLAMINE; N METHYL DEXTRO ASPARTIC ACID; NALOXONE; NALTRINDOLE; PENTAZOCINE; SIGMA OPIATE RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; HIPPOCAMPUS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ACTION POTENTIALS; ANIMALS; CINNAMATES; CYCLAZOCINE; CYCLOHEXYLAMINES; CYCLOPROPANES; EXCITATORY AMINO ACID AGONISTS; INJECTIONS, INTRAVENOUS; MALE; N-METHYLASPARTATE; NALOXONE; NARCOTIC ANTAGONISTS; PENTAZOCINE; PIPERIDINES; PYRAMIDAL CELLS; PYRROLIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SIGMA;

EID: 0035869744     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/1098-2396(20010315)39:4<323::AID-SYN1016>3.0.CO;2-1     Document Type: Article

References (57)

1. Modulation of (+)-(3H) pentazocine to guinea pig cerebellum by divalent cations
2. Respiratory and subjective effects of d and 1 pentazocine
3. Modification of the N-methyl-D-aspartate response by antidepressant σ receptor ligands
4. Biphasic effects of sigma ligands on the neuronal response to N-methyl-D-aspartate
5. Steroid hormone effects on NMDA receptor binding and NMDA receptor mRNA levels in the hypothalamus and cerebral cortex of the adult rat
6. Kappa opioid receptor selective affinity labels: Electrophilic benzene acetamides as kappa eslective opioid antagonists
7. Kappa opiate receptor multiplicity: Evidence for two U50,488 sensitive kappa I subtypes and a novel kappa 3 subtype
8. Delta Opioid affinity and selectivity of 4-hydroxy-3-methoxyindolomorphinan analogues related to naltrindole
9. 2 ligands
10. Effect of high affinity sigma ligands on NMDA-induced hippocampal neuron activation
11. Electrophysiological evidence for the existence of sub-types of sigma receptors in the rat dorsal hippocampus. I. Antagonistic effects of high doses of sertraline, clorgyline and L-687-384
12. Effects of a pertussis toxin pretreatment on the modulation of the NMDA response by sigma ligands and NPY
13. Differential effects of sigma ligands on the N-methyl-D-aspartate response in the Ca1 and Ca3 regions of the dorsal hippocampus: Effect of mossy fiber lesioning
14. 3H](+)pentazocine-defined σ recognition sites by phenytoin
15. Analgesics and others effects of the d and l-isomers of pentazocine
16. Discriminative stimulus properties of dextromethorphan in rats
17. Lysergic acid diethylamide and serotonin: A comparison of effects on serotonergic neurons receiving a serotonergic input
18. 1-binding site
19. Solubilization and characterization of active opiate binding sites from mammalian brain
20. Multiple affinity binding states of the sigma-receptor effect of GTP-binding protein-modifying agents
21. Antagonist of the subjective behaviorial, pupillary, and respiratory depressant effects of cyclazocine by naxolone
22. Electrophysiology of hippocampal neurons. II. After potentials and repetitive firing
23. Studies of analgesic drugs. V111. A psychotomimetic effects
24. Cloning and functional expression of the human type 1 sigma receptor (hSigmaR1)
25. + (GIRK) channel in Xenopus oocytes
26. In vitro selection of peptides acting at a new site of NMDA glutamate receptors
27. Biphasic modulatory action of the selective sigma receptor ligand SR 31742A on N-methyl-D-aspartate-induced neuronal responses in the frontal cortex
28. Mu-opioid receptor specific antagonist cyprodime: Characterization by in vitro radioligand and [35S]GTPgammaS binding assays
29. Emerging concepts concerning drug abuse
30. Pharmacology of opioids
31. The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog
32. The effects of sigma compounds on both NMDA- and non NMDA-mediated neuronal activity in rat hippocampus
33. Binding characteristics of [3H]opioid ligands to active opioid binding sites solubilized from rat brain membranes by glycodeoxycholate and NaCl: The recovery of binding activity by dilution
34. Low dose of 1,3-di(2-tolyl)guanidine (DTG) attenuates MK-801-induced spatial working memory impairment in mice
35. Stimulation of σ ligand binding by phenytoin: Apparent binding site and ligand specificity
36. Effects of drugs that bind to PCP and sigma receptors on punished responding
37. L-687,384 is a potent, selective ligand at the central sigma recognition site
38. 1 binding site by photoaffinity labeling and ligand-directed antibodies
39. 7 isomerase: Identification and characterization of a high affinity binding site for enzyme inhibitors
40. N-methyl-D-aspartate-induced neuronal activation is selectively modulated by sigma receptors
41. 3 hippocampus pyramidal neurons
42. The effects of sigma ligands and of neuropeptide Y on N-methyl-D-aspartate-induced neuronal activation of CA3 dorsal hippocampus neurones are differentially affected by pertussis toxin
43. NE-100, a novel sigma receptor ligand: In vivo tests
44. Multiple morphine and enkephalin receptors and the relief of pain
45. Classification and nomenclature of phencyclidine and sigma receptor sites
46. A proposal for the classification of sigma binding sites
47. JO-1784, a potent and selective ligand for rat and mouse brain sigma sites
48. Purification, pharmacological characterization and photoaffinity labeling of sigma receptors from rat and bovine brain
49. 3H]dopamine
50. Cloning and functional characterization of a σ receptor from rat brain
51. Biochemical, behavioral, and electrophysiologic actions of the selective sigma receptor ligand (+)pentazocine
52. 3H]SKF-10047 to etorphine-inaccessible sites in guinea-pig brain
53. Endogenous ligands for sigma opioid receptors in the brain ("sigmaphin"): Evidence from binding assays
54. Naloxone innacessible sigma receptor in rat central nervous system
55. 3H](+)SKF-10047-binding protein partially purified from rat liver and rat brain membranes: An opioid/sigma receptor?
56. Naltrexone fails to antagonize the effects of PCP and SKF-10047 in the dog